{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:50:34Z","timestamp":1791273034867,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-026-04803-4","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:52:30Z","timestamp":1791269550000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Baseline and cumulative Hemoglobin Glycation Index and incident cardiovascular and cerebrovascular events in adults with early Cardiovascular-Kidney-Metabolic Syndrome: A prospective CHARLS Cohort study"],"prefix":"10.1007","volume":"91","author":[{"given":"Hua-Wei","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang-Ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Zhi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"key":"4803_CR1","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"C.E. Ndumele, J. Rangaswami, S.L. Chow et al., Cardiovascular-kidney-metabolic health: A presidential advisory from the American Heart Association. Circulation. 148, 1606\u20131635 (2023). https:\/\/doi.org\/10.1161\/CIR.0000000000001184","journal-title":"Circulation"},{"key":"4803_CR2","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1161\/CIR.0000000000001191","volume":"148","author":"SS Khan","year":"2023","unstructured":"S.S. Khan, J. Coresh, M.J. Pencina et al., Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating cardiovascular-kidney-metabolic health: A scientific statement from the American Heart Association. Circulation. 148, 1982\u20132004 (2023). https:\/\/doi.org\/10.1161\/CIR.0000000000001191","journal-title":"Circulation"},{"key":"4803_CR3","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"C.E. Ndumele, I.J. Neeland, K.R. Tuttle et al., A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic syndrome: A scientific statement from the American Heart Association. Circulation. 148, 1636\u20131664 (2023). https:\/\/doi.org\/10.1161\/CIR.0000000000001186","journal-title":"Circulation"},{"key":"4803_CR4","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1001\/jamacardio.2023.3241","volume":"8","author":"JW Ostrominski","year":"2023","unstructured":"J.W. Ostrominski, S.V. Arnold, J. Butler et al., Prevalence and overlap of cardiac, renal, and metabolic conditions in US adults, 1999\u20132020. JAMA Cardiol. 8, 1050\u20131060 (2023). https:\/\/doi.org\/10.1001\/jamacardio.2023.3241","journal-title":"JAMA Cardiol."},{"key":"4803_CR5","doi-asserted-by":"publisher","first-page":"968766","DOI":"10.3389\/fendo.2022.968766","volume":"13","author":"Y Wang","year":"2022","unstructured":"Y. Wang, Y. Yu, H. Zhang et al., Cardiovascular and renal burdens among patients with MAFLD and NAFLD in China. Front. Endocrinol. (Lausanne). 13, 968766 (2022). https:\/\/doi.org\/10.3389\/fendo.2022.968766","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"4803_CR6","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1161\/CIR.0000000000001303","volume":"151","author":"SS Martin","year":"2025","unstructured":"S.S. Martin, A.W. Aday, N.B. Allen et al., 2025 Heart disease and stroke statistics: A report of US and global data from the American Heart Association. Circulation. 151, e41\u2013e660 (2025). https:\/\/doi.org\/10.1161\/CIR.0000000000001303","journal-title":"Circulation"},{"key":"4803_CR7","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.2337\/dc23-S002","volume":"46","author":"NA ElSayed","year":"2023","unstructured":"N.A. ElSayed, G. Aleppo, V.R. Aroda et al., Classification and diagnosis of diabetes: Standards of care in diabetes-2023. Diabetes Care. 46, S19\u2013S40 (2023). https:\/\/doi.org\/10.2337\/dc23-S002","journal-title":"Diabetes Care"},{"key":"4803_CR8","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.2337\/diacare.15.12.1835","volume":"15","author":"M Brownlee","year":"1992","unstructured":"M. Brownlee, Glycation products and the pathogenesis of diabetic complications. Diabetes Care. 15, 1835\u20131843 (1992). https:\/\/doi.org\/10.2337\/diacare.15.12.1835","journal-title":"Diabetes Care"},{"key":"4803_CR9","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/jclinpath-2017-204755","volume":"72","author":"L Campbell","year":"2019","unstructured":"L. Campbell, T. Pepper, K. Shipman, HbA1c: A review of non-glycaemic variables. J. Clin. Pathol. 72, 12\u201319 (2019). https:\/\/doi.org\/10.1136\/jclinpath-2017-204755","journal-title":"J. Clin. Pathol."},{"key":"4803_CR10","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1258\/acb.2008.007259","volume":"45","author":"DR Macdonald","year":"2008","unstructured":"D.R. Macdonald, A.M. Hanson, M.R. Holland, B.M. Singh, Clinical impact of variability in HbA1c as assessed by simultaneously measuring fructosamine and use of error grid analysis. Ann. Clin. Biochem. 45, 421\u2013425 (2008). https:\/\/doi.org\/10.1258\/acb.2008.007259","journal-title":"Ann. Clin. Biochem."},{"key":"4803_CR11","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.2337\/db07-1820","volume":"57","author":"PK Khera","year":"2008","unstructured":"P.K. Khera, C.H. Joiner, A. Carruthers et al., Evidence for interindividual heterogeneity in the glucose gradient across the human red blood cell membrane and its relationship to hemoglobin glycation. Diabetes. 57, 2445\u20132452 (2008). https:\/\/doi.org\/10.2337\/db07-1820","journal-title":"Diabetes"},{"key":"4803_CR12","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1196\/annals.1333.094","volume":"1043","author":"SM Brown","year":"2005","unstructured":"S.M. Brown, D.M. Smith, N. Alt et al., Tissue-specific variation in glycation of proteins in diabetes: Evidence for a functional role of amadoriase enzymes. Ann. N Y Acad. Sci. 1043, 817\u2013823 (2005). https:\/\/doi.org\/10.1196\/annals.1333.094","journal-title":"Ann. N Y Acad. Sci."},{"key":"4803_CR13","doi-asserted-by":"publisher","first-page":"359ra130","DOI":"10.1126\/scitranslmed.aaf9304","volume":"8","author":"R Malka","year":"2016","unstructured":"R. Malka, D.M. Nathan, J.M. Higgins, Mechanistic modeling of hemoglobin glycation and red blood cell kinetics enables personalized diabetes monitoring. Sci. Transl Med. 8, 359ra130 (2016). https:\/\/doi.org\/10.1126\/scitranslmed.aaf9304","journal-title":"Sci. Transl Med."},{"key":"4803_CR14","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1089\/dia.2023.0146","volume":"25","author":"TC Dunn","year":"2023","unstructured":"T.C. Dunn, Y. Xu, R.M. Bergenstal et al., Personalized glycated hemoglobin in diabetes management: Closing the gap with glucose management indicator. Diabetes Technol. Ther. 25, S65\u2013S74 (2023). https:\/\/doi.org\/10.1089\/dia.2023.0146","journal-title":"Diabetes Technol. Ther."},{"key":"4803_CR15","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S1056-8727(01)00227-6","volume":"16","author":"JM Hempe","year":"2002","unstructured":"J.M. Hempe, R. Gomez, R.J. Jr McCarter, S.A. Chalew, High and low hemoglobin glycation phenotypes in type 1 diabetes: A challenge for interpretation of glycemic control. J. Diabetes Complications. 16, 313\u2013320 (2002). https:\/\/doi.org\/10.1016\/S1056-8727(01)00227-6","journal-title":"J. Diabetes Complications"},{"key":"4803_CR16","doi-asserted-by":"publisher","first-page":"e00299","DOI":"10.1002\/edm2.299","volume":"4","author":"JM Hempe","year":"2021","unstructured":"J.M. Hempe, S. Yang, S. Liu, D.S. Hsia, Standardizing the haemoglobin glycation index. Endocrinol. Diabetes Metab. 4, e00299 (2021). https:\/\/doi.org\/10.1002\/edm2.299","journal-title":"Endocrinol. Diabetes Metab."},{"key":"4803_CR17","doi-asserted-by":"publisher","first-page":"108223","DOI":"10.1016\/j.jdiacomp.2022.108223","volume":"36","author":"JM Hempe","year":"2022","unstructured":"J.M. Hempe, D.S. Hsia, Variation in the hemoglobin glycation index. J. Diabetes Complications. 36, 108223 (2022). https:\/\/doi.org\/10.1016\/j.jdiacomp.2022.108223","journal-title":"J. Diabetes Complications"},{"key":"4803_CR18","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.2337\/dc14-1844","volume":"38","author":"JM Hempe","year":"2015","unstructured":"J.M. Hempe, S. Liu, L. Myers et al., The hemoglobin glycation index identifies subpopulations with harms or benefits from intensive treatment in the ACCORD trial. Diabetes Care. 38, 1067\u20131074 (2015). https:\/\/doi.org\/10.2337\/dc14-1844","journal-title":"Diabetes Care"},{"key":"4803_CR19","doi-asserted-by":"publisher","first-page":"e002339","DOI":"10.1136\/bmjdrc-2021-002339","volume":"9","author":"KR Klein","year":"2021","unstructured":"K.R. Klein, E. Franek, S. Marso et al., Hemoglobin glycation index, calculated from a single fasting glucose value, as a prediction tool for severe hypoglycemia and major adverse cardiovascular events in DEVOTE. BMJ Open. Diabetes Res. Care. 9, e002339 (2021). https:\/\/doi.org\/10.1136\/bmjdrc-2021-002339","journal-title":"BMJ Open. Diabetes Res. Care"},{"key":"4803_CR20","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1097\/CM9.0000000000002717","volume":"136","author":"Y Wang","year":"2023","unstructured":"Y. Wang, H. Liu, X. Hu et al., Association between hemoglobin glycation index and 5-year major adverse cardiovascular events: The REACTION cohort study. Chin. Med. J. (Engl). 136, 2468\u20132475 (2023). https:\/\/doi.org\/10.1097\/CM9.0000000000002717","journal-title":"Chin. Med. J. (Engl)"},{"key":"4803_CR21","doi-asserted-by":"publisher","first-page":"992252","DOI":"10.3389\/fcvm.2022.992252","volume":"9","author":"S Xu","year":"2022","unstructured":"S. Xu, Z. Qin, R. Yuan et al., The hemoglobin glycation index predicts the risk of adverse cardiovascular events in coronary heart disease patients with type 2 diabetes mellitus. Front. Cardiovasc. Med. 9, 992252 (2022). https:\/\/doi.org\/10.3389\/fcvm.2022.992252","journal-title":"Front. Cardiovasc. Med."},{"key":"4803_CR22","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.jdiacomp.2018.08.007","volume":"32","author":"MK Kim","year":"2018","unstructured":"M.K. Kim, J.S. Jeong, J.S. Yun et al., Hemoglobin glycation index predicts cardiovascular disease in people with type 2 diabetes mellitus: A 10-year longitudinal cohort study. J. Diabetes Complications. 32, 906\u2013910 (2018). https:\/\/doi.org\/10.1016\/j.jdiacomp.2018.08.007","journal-title":"J. Diabetes Complications"},{"key":"4803_CR23","doi-asserted-by":"publisher","first-page":"107673","DOI":"10.1016\/j.jdiacomp.2020.107673","volume":"34","author":"L Zhang","year":"2020","unstructured":"L. Zhang, M. Wang, R. Zhang et al., Hemoglobin glycation index in relationship to the risk of cardiovascular complication in patients with type 2 diabetes: A systematic review and meta-analysis. J. Diabetes Complications. 34, 107673 (2020). https:\/\/doi.org\/10.1016\/j.jdiacomp.2020.107673","journal-title":"J. Diabetes Complications"},{"key":"4803_CR24","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41387-024-00318-x","volume":"14","author":"Z Lin","year":"2024","unstructured":"Z. Lin, J. He, S. Yuan et al., Hemoglobin glycation index and cardiovascular outcomes in patients with diabetes and coronary artery disease: Insights from a large cohort study. Nutr. Diabetes. 14, 69 (2024). https:\/\/doi.org\/10.1038\/s41387-024-00318-x","journal-title":"Nutr. Diabetes"},{"key":"4803_CR25","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1111\/dom.15541","volume":"26","author":"J Yang","year":"2024","unstructured":"J. Yang, Q. Shangguan, G. Xie et al., Sex-specific associations between haemoglobin glycation index and the risk of cardiovascular and all-cause mortality in individuals with pre-diabetes and diabetes: A large prospective cohort study. Diabetes Obes. Metab. 26, 2275\u20132283 (2024). https:\/\/doi.org\/10.1111\/dom.15541","journal-title":"Diabetes Obes. Metab."},{"key":"4803_CR26","doi-asserted-by":"publisher","first-page":"1447184","DOI":"10.3389\/fendo.2024.1447184","volume":"15","author":"L Zhao","year":"2024","unstructured":"L. Zhao, C. Li, H. Lv et al., Association of hemoglobin glycation index with all-cause and cardio-cerebrovascular mortality among people with metabolic syndrome. Front. Endocrinol. (Lausanne). 15, 1447184 (2024). https:\/\/doi.org\/10.3389\/fendo.2024.1447184","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"4803_CR27","doi-asserted-by":"publisher","first-page":"690689","DOI":"10.3389\/fcvm.2021.690689","volume":"8","author":"JD Wu","year":"2021","unstructured":"J.D. Wu, D.L. Liang, Y. Xie et al., Association between hemoglobin glycation index and risk of cardiovascular disease and all-cause mortality in type 2 diabetic patients: A meta-analysis. Front. Cardiovasc. Med. 8, 690689 (2021). https:\/\/doi.org\/10.3389\/fcvm.2021.690689","journal-title":"Front. Cardiovasc. Med."},{"key":"4803_CR28","doi-asserted-by":"publisher","first-page":"e0175547","DOI":"10.1371\/journal.pone.0175547","volume":"12","author":"MA Marini","year":"2017","unstructured":"M.A. Marini, T.V. Fiorentino, E. Succurro et al., Association between hemoglobin glycation index and insulin resistance and carotid atherosclerosis in non-diabetic individuals. PLoS One. 12, e0175547 (2017). https:\/\/doi.org\/10.1371\/journal.pone.0175547","journal-title":"PLoS One"},{"key":"4803_CR29","doi-asserted-by":"publisher","first-page":"147916412095862","DOI":"10.1177\/1479164120958625","volume":"17","author":"D Nagayama","year":"2020","unstructured":"D. Nagayama, Y. Watanabe, T. Yamaguchi et al., High hemoglobin glycation index is associated with increased systemic arterial stiffness independent of hyperglycemia in a real-world Japanese population: A cross-sectional study. Diabetes Vasc Dis. Res. 17, 1479164120958625 (2020). https:\/\/doi.org\/10.1177\/1479164120958625","journal-title":"Diabetes Vasc Dis. Res."},{"key":"4803_CR30","doi-asserted-by":"publisher","first-page":"107760","DOI":"10.1016\/j.jdiacomp.2020.107760","volume":"35","author":"W Kim","year":"2021","unstructured":"W. Kim, T. Go, D.R. Kang et al., Hemoglobin glycation index is associated with incident chronic kidney disease in subjects with impaired glucose metabolism: A 10-year longitudinal cohort study. J. Diabetes Complications. 35, 107760 (2021). https:\/\/doi.org\/10.1016\/j.jdiacomp.2020.107760","journal-title":"J. Diabetes Complications"},{"key":"4803_CR31","doi-asserted-by":"publisher","first-page":"109834","DOI":"10.1016\/j.diabres.2022.109834","volume":"186","author":"CH Lin","year":"2022","unstructured":"C.H. Lin, Y.C. Lai, T.J. Chang et al., Hemoglobin glycation index predicts renal function deterioration in patients with type 2 diabetes and a low risk of chronic kidney disease. Diabetes Res. Clin. Pract. 186, 109834 (2022). https:\/\/doi.org\/10.1016\/j.diabres.2022.109834","journal-title":"Diabetes Res. Clin. Pract."},{"key":"4803_CR32","doi-asserted-by":"publisher","first-page":"109212","DOI":"10.1016\/j.jdiacomp.2025.109212","volume":"40","author":"J He","year":"2026","unstructured":"J. He, H. Zhang, Y. Tan et al., Nonlinear association of the hemoglobin glycation index with all-cause and cardiovascular mortality: A community-based cohort study. J. Diabetes Complications. 40, 109212 (2026). https:\/\/doi.org\/10.1016\/j.jdiacomp.2025.109212","journal-title":"J. Diabetes Complications"},{"key":"4803_CR33","doi-asserted-by":"publisher","first-page":"e007858","DOI":"10.1161\/JAHA.117.007858","volume":"7","author":"JP Mitsios","year":"2018","unstructured":"J.P. Mitsios, E.I. Ekinci, G.P. Mitsios et al., Relationship between glycated hemoglobin and stroke risk: A systematic review and meta-analysis. J. Am. Heart Assoc. 7, e007858 (2018). https:\/\/doi.org\/10.1161\/JAHA.117.007858","journal-title":"J. Am. Heart Assoc."},{"key":"4803_CR34","doi-asserted-by":"publisher","first-page":"23095","DOI":"10.1038\/s41598-025-07833-6","volume":"15","author":"N Jia","year":"2025","unstructured":"N. Jia, X.X. Liu, Impact of hemoglobin glycation index on prognosis in critical patients with acute ischemic stroke: A retrospective cohort study using MIMIC-IV 2.2 database. Sci. Rep. 15, 23095 (2025). https:\/\/doi.org\/10.1038\/s41598-025-07833-6","journal-title":"Sci. Rep."},{"key":"4803_CR35","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s12933-024-02352-6","volume":"23","author":"W Li","year":"2024","unstructured":"W. Li, C. Shen, W. Kong et al., Association between the triglyceride glucose-body mass index and future cardiovascular disease risk in a population with cardiovascular-kidney-metabolic syndrome stage 0\u20133: A nationwide prospective cohort study. Cardiovasc. Diabetol. 23, 292 (2024). https:\/\/doi.org\/10.1186\/s12933-024-02352-6","journal-title":"Cardiovasc. Diabetol."},{"key":"4803_CR36","doi-asserted-by":"publisher","first-page":"104192","DOI":"10.1016\/j.numecd.2025.104192","volume":"35","author":"T Chen","year":"2025","unstructured":"T. Chen, H. Yin, Y. Zhou, M. Liang, Relationship between estimated pulse wave velocity trajectories and cardiovascular disease risk in patients with cardiovascular-kidney-metabolic syndrome stages 0\u20133. Nutr. Metab. Cardiovasc. Dis. 35, 104192 (2025). https:\/\/doi.org\/10.1016\/j.numecd.2025.104192","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"4803_CR37","doi-asserted-by":"publisher","first-page":"1554032","DOI":"10.3389\/fendo.2025.1554032","volume":"16","author":"H Liu","year":"2025","unstructured":"H. Liu, S. Mao, Y. Zhao et al., Association between hemoglobin glycation index and the risk of cardiovascular disease in early-stage cardiovascular-kidney-metabolic syndrome: Evidence from the China Health and Retirement Longitudinal Study. Front. Endocrinol. (Lausanne). 16, 1554032 (2025). https:\/\/doi.org\/10.3389\/fendo.2025.1554032","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"4803_CR38","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/ije\/dys203","volume":"43","author":"Y Zhao","year":"2014","unstructured":"Y. Zhao, Y. Hu, J.P. Smith et al., Cohort profile: The China Health and Retirement Longitudinal Study (CHARLS). Int. J. Epidemiol. 43, 61\u201368 (2014). https:\/\/doi.org\/10.1093\/ije\/dys203","journal-title":"Int. J. Epidemiol."},{"key":"4803_CR39","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1093\/aje\/kwz170","volume":"188","author":"X Chen","year":"2019","unstructured":"X. Chen, E. Crimmins, P.P. Hu et al., Venous blood-based biomarkers in the China Health and Retirement Longitudinal Study: Rationale, design, and results from the 2015 wave. Am. J. Epidemiol. 188, 1871\u20131877 (2019). https:\/\/doi.org\/10.1093\/aje\/kwz170","journal-title":"Am. J. Epidemiol."},{"key":"4803_CR40","doi-asserted-by":"publisher","first-page":"28345","DOI":"10.1038\/s41598-024-80015-y","volume":"14","author":"L Gao","year":"2024","unstructured":"L. Gao, B. Wang, X. Yang et al., Discussion on the calculation formula of haemoglobin glycation index for Chinese population. Sci. Rep. 14, 28345 (2024). https:\/\/doi.org\/10.1038\/s41598-024-80015-y","journal-title":"Sci. Rep."},{"key":"4803_CR41","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jdiacomp.2005.01.004","volume":"19","author":"SA Chalew","year":"2005","unstructured":"S.A. Chalew, R.J. Jr McCarter, J. Thomas et al., A comparison of the glycosylation gap and hemoglobin glycation index in patients with diabetes. J. Diabetes Complications. 19, 218\u2013222 (2005). https:\/\/doi.org\/10.1016\/j.jdiacomp.2005.01.004","journal-title":"J. Diabetes Complications"},{"key":"4803_CR42","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.jdiacomp.2017.04.015","volume":"31","author":"MK Kim","year":"2017","unstructured":"M.K. Kim, J.S. Jeong, H.S. Kwon et al., Concordance of the hemoglobin glycation index with glycation gap using glycated albumin in patients with type 2 diabetes. J. Diabetes Complications. 31, 1127\u20131131 (2017). https:\/\/doi.org\/10.1016\/j.jdiacomp.2017.04.015","journal-title":"J. Diabetes Complications"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04803-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-026-04803-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04803-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:52:32Z","timestamp":1791269552000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-026-04803-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4803"],"URL":"https:\/\/doi.org\/10.1007\/s12020-026-04803-4","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]},"assertion":[{"value":"21 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval for all CHARLS waves was granted by the Institutional Review Board at Peking University. The protocol of fieldwork of the main household survey was approved under reference number IRB00001052-11015. The present study was conducted in accordance with the Declaration of Helsinki and its subsequent amendments.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"323"}}